M. Kyle Cromer

2.3k total citations · 1 hit paper
17 papers, 1.2k citations indexed

About

M. Kyle Cromer is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, M. Kyle Cromer has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Genetics. Recurrent topics in M. Kyle Cromer's work include CRISPR and Genetic Engineering (13 papers), Virus-based gene therapy research (5 papers) and CAR-T cell therapy research (3 papers). M. Kyle Cromer is often cited by papers focused on CRISPR and Genetic Engineering (13 papers), Virus-based gene therapy research (5 papers) and CAR-T cell therapy research (3 papers). M. Kyle Cromer collaborates with scholars based in United States, India and Sweden. M. Kyle Cromer's co-authors include Matthew H. Porteus, Daniel P. Dever, Joab Camarena, Carsten T. Charlesworth, Benjamin J. Lesch, Natalia Gomez‐Ospina, Christopher A. Vakulskas, Mara Pavel-Dinu, Mark A. Behlke and Nicole M. Bode and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

M. Kyle Cromer

15 papers receiving 1.2k citations

Hit Papers

Identification of preexisting adaptive immunity to Cas9 p... 2019 2026 2021 2023 2019 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Identification of preexisting adaptive immunity to Cas9 proteins in humans
    2019 665 citations Carsten T. Charlesworth, Daniel P. Dever et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Kyle Cromer United States 11 992 443 255 125 91 17 1.2k
Giulia Pavani United States 15 783 0.8× 459 1.0× 187 0.7× 75 0.6× 38 0.4× 33 1.1k
Dong Woo Song South Korea 11 926 0.9× 235 0.5× 47 0.2× 52 0.4× 79 0.9× 17 1.0k
Tingting Sui China 19 756 0.8× 264 0.6× 38 0.1× 30 0.2× 55 0.6× 37 859
Zhenning He United States 14 826 0.8× 470 1.1× 84 0.3× 51 0.4× 76 0.8× 23 1.0k
Cheng-Jang Wu United States 9 531 0.5× 155 0.3× 371 1.5× 61 0.5× 20 0.2× 16 1.1k
Carsten T. Charlesworth United States 7 854 0.9× 357 0.8× 157 0.6× 55 0.4× 84 0.9× 10 938
Rosa Romano Italy 12 768 0.8× 331 0.7× 161 0.6× 64 0.5× 71 0.8× 23 1.0k
Sandeep K. Botla Germany 5 912 0.9× 258 0.6× 176 0.7× 69 0.6× 79 0.9× 5 1.0k
Stamatis Papathanasiou United States 6 551 0.6× 144 0.3× 71 0.3× 39 0.3× 42 0.5× 6 666
Alec B. Wilkens United States 3 1.3k 1.4× 446 1.0× 218 0.9× 97 0.8× 146 1.6× 4 1.5k

Countries citing papers authored by M. Kyle Cromer

Since Specialization
Citations

This map shows the geographic impact of M. Kyle Cromer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Kyle Cromer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Kyle Cromer more than expected).

Fields of papers citing papers by M. Kyle Cromer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Kyle Cromer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Kyle Cromer. The network helps show where M. Kyle Cromer may publish in the future.

Co-authorship network of co-authors of M. Kyle Cromer

This figure shows the co-authorship network connecting the top 25 collaborators of M. Kyle Cromer. A scholar is included among the top collaborators of M. Kyle Cromer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Kyle Cromer. M. Kyle Cromer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Perriman, Rhonda, et al.. (2025). Novel humanized loss-of-function NF1 mouse model of juvenile myelomonocytic leukemia. Blood Advances. 10(3). 837–849.
2.
Ekman, Freja K., Sridhar Selvaraj, Eric Soupène, et al.. (2025). Engineering synthetic signaling receptors to enable erythropoietin-free erythropoiesis. Nature Communications. 16(1). 1140–1140. 1 indexed citations
3.
Charlesworth, Carsten T., Anais K. Amaya, Sriram Vaidyanathan, et al.. (2025). Highly efficient in vivo hematopoietic stem cell transduction using an optimized self-complementary adeno-associated virus. Molecular Therapy — Methods & Clinical Development. 33(1). 101438–101438.
4.
Ekman, Freja K., Sridhar Selvaraj, Jason Gotlib, M. Kyle Cromer, & Matthew H. Porteus. (2024). Targeting the JAK2-V617F Mutation in Polycythemia Vera Using CRISPR/AAV6 Genome Editing. Blood. 144(Supplement 1). 4524–4524. 2 indexed citations
5.
Camarena, Joab, Jessica P. Hampton, Carsten T. Charlesworth, et al.. (2024). Enhancement of erythropoietic output by Cas9-mediated insertion of a natural variant in haematopoietic stem and progenitor cells. Nature Biomedical Engineering. 8(12). 1540–1552. 2 indexed citations
6.
Baik, Ron, M. Kyle Cromer, Christopher A. Vakulskas, et al.. (2024). Transient inhibition of 53BP1 increases the frequency of targeted integration in human hematopoietic stem and progenitor cells. Nature Communications. 15(1). 111–111. 8 indexed citations
7.
Selvaraj, Sridhar, Sébastien Viel, Sriram Vaidyanathan, et al.. (2023). High-efficiency transgene integration by homology-directed repair in human primary cells using DNA-PKcs inhibition. Nature Biotechnology. 42(5). 731–744. 40 indexed citations
8.
Cromer, M. Kyle, Garrett R. Rettig, Karthik Murugan, et al.. (2023). Comparative analysis of CRISPR off-target discovery tools following ex vivo editing of CD34+ hematopoietic stem and progenitor cells. Molecular Therapy. 31(4). 1074–1087. 19 indexed citations
9.
Cromer, M. Kyle, Valentin Barsan, Erich Jaeger, et al.. (2022). Ultra-deep sequencing validates safety of CRISPR/Cas9 genome editing in human hematopoietic stem and progenitor cells. Nature Communications. 13(1). 4724–4724. 30 indexed citations
10.
Wienert, Beeke & M. Kyle Cromer. (2022). CRISPR nuclease off-target activity and mitigation strategies. SHILAP Revista de lepidopterología. 4. 1050507–1050507. 25 indexed citations
11.
Martin, Renata M., Jonas L. Fowler, M. Kyle Cromer, et al.. (2020). Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards. Nature Communications. 11(1). 2713–2713. 72 indexed citations
12.
Alencastro, Gustavo de, Francesco Puzzo, Mara Pavel-Dinu, et al.. (2020). Improved Genome Editing through Inhibition of FANCM and Members of the BTR Dissolvase Complex. Molecular Therapy. 29(3). 1016–1027. 10 indexed citations
13.
Charlesworth, Carsten T., Daniel P. Dever, Joab Camarena, et al.. (2019). Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nature Medicine. 25(2). 249–254. 665 indexed citations breakdown →
14.
Cromer, M. Kyle, Sriram Vaidyanathan, Daniel E. Ryan, et al.. (2018). Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34+ Hematopoietic Stem and Progenitor Cells. Molecular Therapy. 26(10). 2431–2442. 87 indexed citations
15.
Charlesworth, Carsten T., Joab Camarena, M. Kyle Cromer, et al.. (2018). Priming Human Repopulating Hematopoietic Stem and Progenitor Cells for Cas9/sgRNA Gene Targeting. Molecular Therapy — Nucleic Acids. 12. 89–104. 76 indexed citations
16.
Cromer, M. Kyle, Murim Choi, Carol Nelson‐Williams, et al.. (2015). Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomas. Proceedings of the National Academy of Sciences. 112(13). 4062–4067. 53 indexed citations
17.
Cromer, M. Kyle, Lee F. Starker, Murim Choi, et al.. (2012). Identification of Somatic Mutations in Parathyroid Tumors Using Whole-Exome Sequencing. The Journal of Clinical Endocrinology & Metabolism. 97(9). E1774–E1781. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giulia Pavani Breakdown of academic impact, for papers by Dong Woo Song Breakdown of academic impact, for papers by Tingting Sui Breakdown of academic impact, for papers by Zhenning He Breakdown of academic impact, for papers by Cheng-Jang Wu Breakdown of academic impact, for papers by Carsten T. Charlesworth Breakdown of academic impact, for papers by Rosa Romano Breakdown of academic impact, for papers by Sandeep K. Botla Breakdown of academic impact, for papers by Stamatis Papathanasiou Breakdown of academic impact, for papers by Alec B. Wilkens
Rankless by CCL
2026